Intrexon | Ativos





Ativos Alterar Data
Agenus USD 233.89M 48.67M 2025-09
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
Amgen USD 90.59B 445M 2025-12
Anika Therapeutics USD 189.44M 1.76M 2025-09
Arrowhead Research USD 1.6B 218.89M 2025-12
AstraZeneca USD 114.07B 382M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
Heron Therapeutics USD 248.95M 16.86M 2025-09
Incyte USD 6.96B 627.62M 2025-12
Intrexon USD 73.16M 77.88M 2024-06
Karyopharm Therapeutics USD 96.23M 8.65M 2025-09
Ligand Pharmaceuticals USD 1.48B 528.17M 2025-09
MacroGenics USD 270.76M 25.34M 2025-09
MannKind USD 494.64M 82.94M 2025-09
Merck USD 129.55B 12.02B 2025-09
Novartis USD 107.29B 2.89B 2025-09
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
Veracyte USD 1.37B 23.68M 2025-09
Xencor USD 868.81M 10.61M 2025-09


Intrexon Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.